L-Dex Abstracts to be Presented at Breast Cancer Symposium
Filed with ASX · · 2 pages · English
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallIn the deck
Earlier from Impedimed
- 2018 Reimbursement Amounts Published by CMS
- Multi-year Exclusive Distribution Agreement Signed
- Appendix 4C - Quarter ended 30 September 2017
- Shipments of SOZO with L-Dex Commence in the US
- New Study Reports Superior Clinical Outcomes Utilising L-Dex
Later from Impedimed
- US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO
- Appendix 4C - Quarter ended 31 December 2017
- ImpediMed & Sharp HealthCare Sign Agreement for SOZO
- US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment
- Interim Results of PREVENT Trial
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed